Literature DB >> 6816619

The influence of free fatty acids on valproic acid plasma protein binding during fasting in normal humans.

T A Bowdle, I H Patel, R H Levy, A J Wilensky.   

Abstract

The effect of physiologic variations of free fatty acid levels on in vivo valproic acid plasma protein binding was studied in 6 healthy adult subjects. 14 blood samples were taken during a 12-h dosing interval at steady state while in a fed condition and also during a 27 h fast. Free fraction and total valproate concentration were determined by equilibrium dialysis and GLC, respectively. Free fatty acid levels were determined from both fresh samples and samples incubated at 37 degrees C for 12 h, the latter in order to simulate equilibrium dialysis conditions. Fasting resulted in increased serum free fatty acid levels in all subjects, ranging from 34-182% (p less than 0.01). Incubation also caused free fatty acid levels to rise, more so in fed samples (50-87%, p less than 0.01) than in fasting samples (10-50%, p less than 0.01). Fasting resulted in a 9% increase in the mean free fraction for all subjects combined (P less than 0.01). Regression analysis of 180 sets of values for free fraction, total valproate concentration and free fatty acid level suggested that valproate concentration accounts for 17% and free fatty acid level for 37% of the variation in free fraction. Mean clearance was unchanged by fasting despite an increased free fraction suggesting decreased intrinsic clearance (i.e. decreased metabolism) of valproate under these conditions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6816619     DOI: 10.1007/bf00613618

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  THE COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA.

Authors:  W G DUNCOMBE
Journal:  Clin Chim Acta       Date:  1964-02       Impact factor: 3.786

2.  Serum protein binding of valproic acid and its displacement by palmitic acid in vitro.

Authors:  A Monks; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

3.  Metabolism of valproate sodium in rabbit, rat, dog, and man.

Authors:  B Ferrandes; P Eymard
Journal:  Epilepsia       Date:  1977-06       Impact factor: 5.864

4.  A method for determination of free fatty acids in serum.

Authors:  D Mikac-Dević; H Stanković; K Bosković
Journal:  Clin Chim Acta       Date:  1973-04-19       Impact factor: 3.786

5.  Hepatic extraction of endogenous inhibitors of plasma protein binding.

Authors:  U W Wiegand; G Levy
Journal:  J Pharm Sci       Date:  1980-04       Impact factor: 3.534

6.  Identification of metabolites of valproic acid in serum of humans, dog, rat, and mouse.

Authors:  C Jakobs; W Löscher
Journal:  Epilepsia       Date:  1978-12       Impact factor: 5.864

7.  Valproic acid: in vitro plasma protein binding and interaction with phenytoin.

Authors:  J A Cramer; R H Mattson
Journal:  Ther Drug Monit       Date:  1979       Impact factor: 3.681

8.  Pharmacokinetic studies with valproic acid in man.

Authors:  U Klotz
Journal:  Arzneimittelforschung       Date:  1977

9.  Effects of carbamazepine on valproic acid kinetics in normal subjects.

Authors:  T A Bowdle; R H Levy; R E Cutler
Journal:  Clin Pharmacol Ther       Date:  1979-11       Impact factor: 6.875

10.  Valproic acid dosage and plasma protein binding and clearance.

Authors:  A T Bowdle; I H Patel; R H Levy; A J Wilensky
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

View more
  3 in total

Review 1.  Influence of exercise on the pharmacokinetics of drugs.

Authors:  M A van Baak
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

2.  Nonlinear binding of valproic acid (VPA) and E-delta 2-valproic acid to rat plasma proteins.

Authors:  R L Semmes; D D Shen
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

Review 3.  Drug interactions with valproic acid.

Authors:  R H Levy; K M Koch
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.